Upharmacia September 2017
CIS PHARMA NEWS
Azerbaijan ——
The Head of the MoH of Belarus stated that his government is interested in establishing of joint pharmaceutical enterprise in Azerbaijan . Azerbaijani government plans to involve Azerbaijan Investment Company in the project .
——
Within the Memorandum signed between Ministry of Economy of Azerbaijan and LLC Hayat Pharm , the creation of the Association of pharmaceutical production manufacturers in Azerbaijan has been agreed .
——
The government regulated prices of 10 ths drugs registered in Azerbaijan .
Belarus ——
Within the Belarusian-Indian Business Forum , the parties reached the number of cooperation agreements . The MOH of Belarus general agreement on strategic partnership with Hetero Labs Limited company . Trilateral agreement on the basic conditions between the MOH , Glorinkor Company ( Belarus ) and Biocon Limited ( India ). Same agreement between the MOH , Glorinkor Company and Cadila Healthcare Limited ( India ).
——
Leading Belarussian producer of pharmaceuticals Belmedpreparaty will establish experimental production of oral antitumor drugs using isolating technologies . The project envisages implementation of international GMP standards .
——
Veropharm company ( part of Abbott Group ) reached strategic partnership agreement with the Russian producer of pharmaceutical substances Bion . The companies will cooperate in development and production of drugs for cancer treatment , cardiovascular and central nervous system .
——
The GM of BIOCAD company , stated that in 2-3 years Russian generic market would collapse – prices for this category of drugs to drop significantly , while the generic market to cease to be the driver of the development of the pharmaceutical industry .
Kazakhstan ——
Jordanian company Hikma Pharmaceuticals PLC signed investment contract with Kazakh government to build the pharmaceutical plant in Alatau industrial zone ( Almaty city ). The company also signed a 10-year contract with Single Distributor SK-Pharmacy on the supply of drugs on an exclusive basis .
——
According to the MOH ’ s plan the regulation of Rx drugs prices will be implemented in 2018 , OTC – in 2023 .
Russia ——
Venture Biotech Fund Primer Capital invested in the development of the drug by Gemopharm company for the treatment of multiple myeloma . The drug has already shown high efficacy in vivo .
——
BIOCAD company will build a production complex in Pushkin district in St . Petersburg . It will include the center for pre-clinical trials , as well as production of substances and finished drugs . The investments to amount RUB 3bn .
www . upharma-c . com
9